Growth Metrics

Cogent Biosciences (COGT) Consolidated Net Income: 2017-2020

Historic Consolidated Net Income for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$82.1 million.

  • Cogent Biosciences' Consolidated Net Income fell 594.78% to -$11.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$82.1 million, marking a year-over-year decrease of 157.14%. This contributed to the annual value of -$82.1 million for FY2020, which is 157.14% down from last year.
  • Cogent Biosciences' Consolidated Net Income amounted to -$82.1 million in FY2020, which was down 157.14% from -$31.9 million recorded in FY2019.
  • In the past 5 years, Cogent Biosciences' Consolidated Net Income ranged from a high of -$25.8 million in FY2017 and a low of -$82.1 million during FY2020.
  • Over the past 3 years, Cogent Biosciences' median Consolidated Net Income value was -$34.9 million (recorded in 2018), while the average stood at -$49.6 million.
  • In the last 5 years, Cogent Biosciences' Consolidated Net Income rose by 8.44% in 2019 and then plummeted by 157.14% in 2020.
  • Cogent Biosciences' Consolidated Net Income (Yearly) stood at -$25.8 million in 2017, then slumped by 35.26% to -$34.9 million in 2018, then increased by 8.44% to -$31.9 million in 2019, then plummeted by 157.14% to -$82.1 million in 2020.